Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Inhibitors of calmodulin-dependent PDE discovered at Daiichi

Jan. 5, 2000

Delayed treatment with AM-36 reduces neuronal damage in stroke model

Jan. 5, 2000

Pharmacia & Upjohn scientists isolate Alzheimer's-related gene

Jan. 4, 2000

Potent new nonpeptide bradykinin B2 receptor antagonist selected by Fournier for further development

Jan. 3, 2000

NDA filed for intranasal scopolamine during fourth quarter

Jan. 3, 2000

Metabotropic glutamate receptor agonist tested in anxiety and addiction models

Jan. 3, 2000

Irbesartan and other selective AT1 receptor antagonists may offer new approach to stroke management

Dec. 30, 1999

Elan seeks U.S. approval for ziconotide

Dec. 30, 1999

Schwarz obtains expanded rights to develop and market antiparkinsonian patch

Dec. 30, 1999

Reboxetine + pindolol rapidly relieves symptoms of depression and other CNS disorders

Dec. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...